Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Conditions:   Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions:   Drug: Vismodegib;   Radiation: Radiation therapy
Sponsors:   Sue Yom;   Genentech, Inc.
Recruiting - verified November 2016

http://ift.tt/2f8KTRm